文献速递头颈外科咽喉与嗓音

低至中危扁桃体癌原发经口机器人手术与单侧或双侧放疗后的吞咽功能

Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer.
PubMed 文献 · Otolaryngol Head Neck Surg · 2021-11-16

该研究为单中心前瞻性队列的二次分析,纳入135例HPV/p16阳性扁桃体鳞癌患者,比较原发经口机器人手术(TORS)、单侧放疗(uniRT)与双侧放疗(biRT)后的吞咽结局。结果显示各组MDADI评分无显著差异,TORS与uniRT提供最佳吞咽功能相关结局,但喂养管放置率与持续时间因治疗策略而异,可能反映吞咽困难以外的毒性。

要点

  • 基线DIGEST分级在治疗组间显著不同,TORS组吞咽困难患病率34%高于biRT组12%(P = .04)。
  • 亚急性期和纵向时间点DIGEST分级及吞咽困难患病率组间无显著差异(P = .41)。
  • 喂养管放置率与持续时间组间显著不同:TORS 89%(中位3天)、uniRT 8%(中位82天)、biRT 37%(中位104天),P < .001。

核心结论

  • TORS与uniRT提供最佳的吞咽困难相关功能结局,但结果提示这些原发治疗策略与biRT之间在临床医生分级或患者报告的吞咽结局上无显著差异。
  • 除驱动治疗选择的基线差异外,喂养管放置率与持续时间因原发治疗策略而异,可能反映吞咽困难以外的多种毒性。

研究设计与样本

  • 研究设计为前瞻性队列的二次分析,设置于单中心。
  • 研究样本为135例HPV/p16阳性、T1-T3、N0-2b(美国癌症联合委员会第七版)、N0-1(第八版)扁桃体鳞状细胞癌患者,取自前瞻性登记数据库。
  • 收集改良钡餐吞咽检查按DIGEST分级、喂养管放置与持续时间及MDADI。

主要发现

  • 基线DIGEST分级在治疗组间显著不同,TORS组吞咽困难患病率34% vs biRT组12%(P = .04)。
  • 亚急性期和纵向时间点DIGEST分级或吞咽困难患病率无显著组间差异(P = .41)。
  • 平均MDADI评分基线时组间相似(TORS 92;uniRT 93;biRT 93;P = .90),亚急性期(TORS 83;uniRT 88;biRT 82;P = .38)和晚期时间点(TORS 86;uniRT 86;biRT 87;P = .99)亦相似。
  • 喂养管放置率与持续时间在原发治疗组间显著不同(喂养管[中位天数]:TORS 89%[3];uniRT 8%[82];biRT 37%[104];P < .001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The primary course of treatment for patients with low- to intermediate-risk tonsil cancer has evolved with a shift toward primary transoral robotic surgery (TORS) or radiation therapy (RT). While favorable outcomes have been reported after deintensification via unilateral TORS or RT (uniRT), comparisons of functional outcomes between these treatments are lacking. We compared clinical outcomes (Dynamic Imaging Grade of Swallowing Toxicity [DIGEST] and feeding tube [FT]) and patient-reported swallowing outcomes (MD Anderson Dysphagia Inventory [MDADI]) based on primary treatment strategy: TORS, uniRT, or bilateral RT (biRT). STUDY DESIGN: Secondary analysis of prospective cohort. SETTING: Single institution. METHODS: The study sample comprised 135 patients with HPV/p16+ T1-T3, N0-2b (American Joint Committee on Cancer, seventh edition), N0-1 (eighth edition) squamous cell carcinoma of the tonsil were sampled from a prospective registry. Modified barium swallow studies graded per DIGEST, FT placement and duration, and MDADI were collected. RESULTS: Baseline DIGEST grade significantly differed among treatment groups, with higher dysphagia prevalence in the TORS group (34%) vs the biRT group (12%, P = .04). No significant group differences were found in DIGEST grade or dysphagia prevalence at subacute and longitudinal time points (P = .41). Mean MDADI scores were similar among groups at baseline (TORS, 92; uniRT, 93; biRT, 93; P = .90), subacute (TORS, 83; uniRT, 88; biRT, 82; P = .38) and late time points (TORS, 86; uniRT, 86; biRT, 87; P = .99). FT placement and duration significantly differed among primary treatment groups (FT [median days]: TORS, 89% [3]; uniRT, 8% [82]; biRT, 37% [104]; P < .001). CONCLUSION: While TORS and uniRT offer optimal functional outcomes related to dysphagia, results suggest that no measurable clinician-graded or patient-reported differences in swallow outcomes exist among these primary treatment strategies and biRT. Aside from baseline differences that drive treatment selection, differences in FT rate and duration by primary treatment strategy likely reflect diverse toxicities beyond dysphagia.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Barbon CEA, Yao CMK, Peterson CB, et al. Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer. Otolaryngol Head Neck Surg. 2021. PMID: 34784256. doi:10.1177/01945998211059967

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。